These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 21351858)

  • 1. Comparative effectiveness research: guidelines for good practices are just the beginning.
    Johnson ML; Chitnis AS
    Expert Rev Pharmacoecon Outcomes Res; 2011 Feb; 11(1):51-7. PubMed ID: 21351858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Good research practices for comparative effectiveness research: defining, reporting and interpreting nonrandomized studies of treatment effects using secondary data sources: the ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report--Part I.
    Berger ML; Mamdani M; Atkins D; Johnson ML
    Value Health; 2009; 12(8):1044-52. PubMed ID: 19793072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Good research practices for comparative effectiveness research: approaches to mitigate bias and confounding in the design of nonrandomized studies of treatment effects using secondary data sources: the International Society for Pharmacoeconomics and Outcomes Research Good Research Practices for Retrospective Database Analysis Task Force Report--Part II.
    Cox E; Martin BC; Van Staa T; Garbe E; Siebert U; Johnson ML
    Value Health; 2009; 12(8):1053-61. PubMed ID: 19744292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ISPOR Good Practices for Quality Improvement of Cost-Effectiveness Research Task Force Report.
    McGhan WF; Al M; Doshi JA; Kamae I; Marx SE; Rindress D
    Value Health; 2009; 12(8):1086-99. PubMed ID: 19744291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Good research practices for comparative effectiveness research: analytic methods to improve causal inference from nonrandomized studies of treatment effects using secondary data sources: the ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report--Part III.
    Johnson ML; Crown W; Martin BC; Dormuth CR; Siebert U
    Value Health; 2009; 12(8):1062-73. PubMed ID: 19793071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective observational studies to assess comparative effectiveness: the ISPOR good research practices task force report.
    Berger ML; Dreyer N; Anderson F; Towse A; Sedrakyan A; Normand SL
    Value Health; 2012; 15(2):217-30. PubMed ID: 22433752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Good Practices for Real-World Data Studies of Treatment and/or Comparative Effectiveness: Recommendations from the Joint ISPOR-ISPE Special Task Force on Real-World Evidence in Health Care Decision Making.
    Berger ML; Sox H; Willke RJ; Brixner DL; Eichler HG; Goettsch W; Madigan D; Makady A; Schneeweiss S; Tarricone R; Wang SV; Watkins J; Mullins CD
    Value Health; 2017 Sep; 20(8):1003-1008. PubMed ID: 28964430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report.
    Ramsey S; Willke R; Briggs A; Brown R; Buxton M; Chawla A; Cook J; Glick H; Liljas B; Petitti D; Reed S
    Value Health; 2005; 8(5):521-33. PubMed ID: 16176491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methodological challenges of comparative effectiveness research in pain: implications for investigators, clinicians, and policy makers.
    Bellows BK; Biskupiak J
    J Pain Palliat Care Pharmacother; 2011; 25(3):267-74. PubMed ID: 21882980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conducting indirect-treatment-comparison and network-meta-analysis studies: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 2.
    Hoaglin DC; Hawkins N; Jansen JP; Scott DA; Itzler R; Cappelleri JC; Boersma C; Thompson D; Larholt KM; Diaz M; Barrett A
    Value Health; 2011 Jun; 14(4):429-37. PubMed ID: 21669367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling good research practices--overview: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--1.
    Caro JJ; Briggs AH; Siebert U; Kuntz KM;
    Value Health; 2012; 15(6):796-803. PubMed ID: 22999128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GRACE principles: recognizing high-quality observational studies of comparative effectiveness.
    Dreyer NA; Schneeweiss S; McNeil BJ; Berger ML; Walker AM; Ollendorf DA; Gliklich RE;
    Am J Manag Care; 2010 Jun; 16(6):467-71. PubMed ID: 20560690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Creating a high-performance system for comparative effectiveness research.
    Etheredge LM
    Health Aff (Millwood); 2010 Oct; 29(10):1761-7. PubMed ID: 20921473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Updating comparative effectiveness reviews: current efforts in AHRQ's Effective Health Care Program.
    Tsertsvadze A; Maglione M; Chou R; Garritty C; Coleman C; Lux L; Bass E; Balshem H; Moher D
    J Clin Epidemiol; 2011 Nov; 64(11):1208-15. PubMed ID: 21684114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of best practices in conducting comparative-effectiveness reviews.
    Guise JM; Viswanathan M
    Clin Pharmacol Ther; 2011 Dec; 90(6):876-82. PubMed ID: 22048219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methodological issues in comparative effectiveness research: clinical trials.
    Peduzzi P; Kyriakides T; O'Connor TZ; Guarino P; Warren SR; Huang GD
    Am J Med; 2010 Dec; 123(12 Suppl 1):e8-15. PubMed ID: 21184867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On guidelines for comparative effectiveness research using nonrandomized studies in secondary data sources.
    Schneeweiss S
    Value Health; 2009; 12(8):1041. PubMed ID: 19744290
    [No Abstract]   [Full Text] [Related]  

  • 18. Invited article: comparative effectiveness research, evidence-based medicine, and the AAN.
    French JA; England JD
    Neurology; 2010 Aug; 75(6):562-7. PubMed ID: 20697109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scientific and organizational collaboration in comparative effectiveness research: the VA cooperative studies program model.
    Huang GD; Ferguson RE; Peduzzi PN; O'Leary TJ
    Am J Med; 2010 Dec; 123(12 Suppl 1):e24-31. PubMed ID: 21184863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Designing quality health services research: why comparative effectiveness studies are needed and why pharmacists should be involved.
    Carter BL
    Pharmacotherapy; 2010 Aug; 30(8):751-7. PubMed ID: 20653349
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.